News
4d
The Brighterside of News on MSNScientists edit mitochondrial DNA to reverse genetic diseases which often have no cureFor decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...
1d
News-Medical.Net on MSNElegen and Nutcracker Therapeutics to pilot first fully cell-free manufacturing process for RNA-based personalized cancer therapeuticsElegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation ...
Humans have been getting infected by ancient bacteria and viruses for at least 37,000 years. Now, for the first time, ...
He and a colleague proved a theory advanced by the Nobel Prize winners James Watson and Francis Crick, who discovered DNA’s ...
People with an underactive thyroid may have an increased risk of developing small intestinal bacterial overgrowth (SIBO), a ...
A rare form of leprosy may have existed in the Americas long before European colonization, according to new research using ...
Powerful new applications of what is known as next-generation sequencing are now helping with identification of degraded ...
"How a common antibiotic fuels bacterial resistance." ScienceDaily. www.sciencedaily.com / releases / 2025 / 06 / 250609073225.htm (accessed June 11, 2025). Explore More ...
Future tests may rely on metagenomics (studying bacterial DNA) and metabolomics (analyzing the chemical products of metabolism) to detect imbalances more precisely [9].
Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results